Realistic Throat and Nasal Cast Models

The standard Ph.Eur./USP Induction Port is known to poorly represent aerosol transport through the upper respiratory tract. Using more realistic throat and nasal cavity models enables a more representative assessment of drug delivery to the target site.

Alberta Idealised Nasal Inlet AINI

Alberta Idealised Nasal Inlet AINI

Understanding and optimising regional deposition is essential to maximise the fraction of drug absorbed via the target pathway and to minimise drug transit to the lungs. For nasally inhaled products, the AINI nasal cast enables representative testing of the deposition of drug within the nasal airways.

  • Idealised geometry representing a range of patient groups
  • Smooth, uniform internal geometry
  • Quick-release clips make internal coating and drug recovery quick and simple
  • Seals ensure leak-free testing
  • Chemically compatible with a range of solvents
  • Manufactured from aluminium for durability and to ensure dimensional reproducibility

Regions represented by the Alberta Idealised Nasal Inlet AINI

The AINI accurately mimics deposition behaviour in each region, allowing the collection of drug samples that reflect the corresponding fraction of the dose for analysis.

The AINI has a four-region resolution:

  • the vestibule
  • the turbinates
  • the olfactory region
  • the nasopharynx

The AINI is easily separated into its component parts to enable drug recovery and assay for each individual area. The AINI comes complete with mensuration and test certificates.

The nasal model we offer was developed from extensive research into typical patient populations including information provided by CT and MRI scans, direct observation of living subjects and data in the archival literature. More information and references are available on request.

System for Improved In Vitro-In Vivo Correlations (IVIVCs) of Inhaled Drug Products

Play Video

Related Services

Related News & Resources

New IPAC-RS paper offers insight and guidance for testing aqueous nasal inhalation products

2nd November 2023

Find out more

Introducing Inhalytix®: a new solution for analysing and managing inhaler test data from Copley

18th March 2021

Find out more

Copley introduces a comprehensive range for nasal product testing

11th March 2021

Find out more

Copley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio

1st March 2021

Find out more

Nasal Product Testing Brochure 2023

View download

Improving the Utility of In Vitro Test Methods for Intranasal Drug Delivery

View download

Benchmarking of Particle Engineering Strategies for Nasal Powder Delivery: Characterization of Nasal Deposition using the Alberta Idealized Nasal Inlet

View download

Nasal Drug Product Development

View download

In Vitro Regional Deposition of Nasal Sprays in an Idealized Nasal Inlet: Comparison with In Vivo Gamma Scintigraphy

View download

Improving In Vitro Test Methods for Nasal Drug Products

View download

Refining Test Methods for a New Generation of Nasal Drug Products

View download

A short Q&A with our CEO, Mark Copley, On Inhaled Product Testing

View download

The Regulatory Landscape for OINDPs – The Biggest Shake-up in A Generation?

View download

Optimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Orally Inhaled Products

View download

Demonstrating Bioequivalence of Orally Inhaled Products

View download

Optimising the Application of In Vitro Test Methods for the Demonstration of BE in OIPs

View download

Characterizing the Performance of Metered Dose Inhalers with Add-On Devices: New Methods For Clinically Relevant Testing

View download